Dysregulation of system xc(-) expression induced by mutant huntingtin in a striatal neuronal cell line and in R6/2 mice.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neurochemistry International

• Publication date

  2014-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neuint.2014.06.017PMID 25004085PMCID PMC4186714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Cystine/Glutamate Antiporter System xc − in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities

  2013cited by this paper
• Glutamate transporter expression and function in a striatal neuronal model of Huntington's disease.

  2013influential reference
• Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease.

  2013influential reference
• Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress

  2013cited by this paper
• Reagents that block neuronal death from Huntington’s disease also curb oxidative stress

  2012cited by this paper
• PGC-1α Rescues Huntington’s Disease Proteotoxicity by Preventing Oxidative Stress and Promoting TFEB Function

  2012cited by this paper
• System xc‐ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS

  2012cited by this paper
• Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells.

  2012influential reference
• Mitochondrial dysfunction, metabolic deficits, and increased oxidative stress in Huntington's disease.

  2011cited by this paper
• Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.

  2011cited by this paper
• Regulation of the System x−C cystine/glutamate exchanger by intracellular glutathione levels in rat astrocyte primary cultures

  2011cited by this paper
• In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects

  2010cited by this paper
• Huntington's disease out of the closet?

  2010cited by this paper
• Huntington's disease out of the closet?

  2010cited by this paper
• Aberrant Rab11-Dependent Trafficking of the Neuronal Glutamate Transporter EAAC1 Causes Oxidative Stress and Cell Death in Huntington's Disease

  2010influential reference
• ATF4-dependent transcription mediates signaling of amino acid limitation.

  2009cited by this paper
• The glutamate homeostasis hypothesis of addiction

  2009cited by this paper
• Basal Levels of eIF2α Phosphorylation Determine Cellular Antioxidant Status by Regulating ATF4 and xCT Expression*

  2009cited by this paper
• Mitochondria and Huntington's Disease Pathogenesis

  2008cited by this paper
• Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse.

  2008cited by this paper
• ATF4 is an oxidative stress–inducible, prodeath transcription factor in neurons in vitro and in vivo

  2008cited by this paper
• Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo1H NMR spectroscopy

  2007cited by this paper
• Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington’s disease gene carriers and healthy subjects

  2007cited by this paper
• Global changes to the ubiquitin system in Huntington's disease

  2007cited by this paper
• Unbiased Gene Expression Analysis Implicates the huntingtin Polyglutamine Tract in Extra-mitochondrial Energy Metabolism

  2007influential reference
• N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease.

  2007cited by this paper
• Transcriptional signatures in Huntington's disease.

  2007cited by this paper
• Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.

  2006cited by this paper
• Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport

  2006cited by this paper
• Brain-specific factors in combination with mutant huntingtin induce gene-specific transcriptional dysregulation.

  2006cited by this paper
• Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.

  2006cited by this paper
• DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations.

  2006cited by this paper
• Distribution of the Cystine/Glutamate Antiporter System x− c in the Brain, Kidney, and Duodenum

  2006cited by this paper
• Transcriptional Repression of PGC-1a by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration

  2006cited by this paper
• Cystine/Glutamate Exchange Modulates Glutathione Supply for Neuroprotection from Oxidative Stress and Cell Proliferation

  2006cited by this paper
• Oxidative Damage in Huntington's Disease Pathogenesis

  2006cited by this paper
• Cooperative action of glutamate transporters and cystine/glutamate antiporter system Xc– protects from oxidative glutamate toxicity

  2006cited by this paper
• Expression of the cystine-glutamate exchanger (xc−) in retinal ganglion cells and regulation by nitric oxide and oxidative stress

  2006influential reference
• Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse

  2006cited by this paper
• Increased glutathione levels in cortical and striatal mitochondria of the R6/2 Huntington's disease mouse model.

  2005cited by this paper
• Inhibition of Cystine Uptake Disrupts the Growth of Primary Brain Tumors

  2005cited by this paper
• Cystamine increases l‐cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation

  2004cited by this paper
• Nuclear Factor E2-Related Factor 2-Dependent Antioxidant Response Element Activation by tert-Butylhydroquinone and Sulforaphane Occurring Preferentially in Astrocytes Conditions Neurons against Oxidative Insult

  2004cited by this paper
• Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation.

  2004cited by this paper
• Glutathione Pathways in the Brain

  2003cited by this paper
• Cerebral cystine uptake: a tale of two transporters.

  2002cited by this paper
• Therapeutic Effects of Coenzyme Q10 and Remacemide in Transgenic Mouse Models of Huntington's Disease

  2002cited by this paper
• Electrophile Response Element-mediated Induction of the Cystine/Glutamate Exchange Transporter Gene Expression*

  2002cited by this paper
• Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6‐hydroxydopamine

  2001cited by this paper
• Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells.

  2001cited by this paper
• Dibutyryl‐cAMP (dbcAMP) up‐regulates astrocytic chloride‐dependent l‐[3H]glutamate transport and expression of both system xc− subunits

  2001cited by this paper
• Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice.

  2000cited by this paper
• Glutathione metabolism and oxidative stress in neurodegeneration

  2000cited by this paper
• Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells.

  2000influential reference
• Transcriptional dysregulation in Huntington's disease.

  2000cited by this paper
• Glioma cells release excitotoxic concentrations of glutamate.

  1999influential reference
• Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function.

  1999cited by this paper
• Cloning and Expression of a Plasma Membrane Cystine/Glutamate Exchange Transporter Composed of Two Distinct Proteins*

  1999influential reference
• Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex.

  1999cited by this paper
• Maturation-Dependent Vulnerability of Oligodendrocytes to Oxidative Stress-Induced Death Caused by Glutathione Depletion

  1998influential reference
• Homocysteic and homocysteine sulphinic acid exhibit excitotoxicity in organotypic cultures from rat brain

  1998cited by this paper
• A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion.

  1997cited by this paper
• Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia

  1997cited by this paper
• Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

  1996cited by this paper
• Interaction of L‐cysteine with a human excitatory amino acid transporter.

  1996cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Oxidative stress, glutamate, and neurodegenerative disorders.

  1993cited by this paper
• Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture

  1992cited by this paper
• Excitotoxic injury of the neostriatum: a model for Huntington's disease.

  1990cited by this paper
• Depletion of tissue glutathione with diethyl maleate enhances hyperbaric oxygen toxicity.

  1990cited by this paper
• Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake

  1990influential reference
• Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex.

  1989cited by this paper
• Exchange of cystine and glutamate across plasma membrane of human fibroblasts.

  1986influential reference
• Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture.

  1980cited by this paper
• Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues.

  1969cited by this paper

• Hydrogen Sulfide Signaling in Neurodegenerative Movement Disorders.

  2025cites this paper
• Oxidative Stress in Huntington’s Disease

  2025cites this paper
• Amino Acid Transporters in Neurological Disorders and Neuroprotective Effects of Cysteine Derivatives.

  2024cites this paper
• An exploratory metabolomic comparison of participants with fast or absent functional progression from 2CARE, a randomized, double-blind clinical trial in Huntington’s disease

  2024cites this paper
• Hydrogen sulfide signalling in neurodegenerative diseases

  2023cites this paper
• Mutant Huntingtin Derails Cysteine Metabolism in Huntington’s Disease at Both Transcriptional and Post-Translational Levels

  2022cites this paper
• Cysteine metabolism and hydrogen sulfide signaling in Huntington's disease.

  2022cites this paper
• Signaling Overlap between the Golgi Stress Response and Cysteine Metabolism in Huntington’s Disease

  2021cites this paper
• Fibroblast Growth Factor 9 Stimulates Neuronal Length Through NF-kB Signaling in Striatal Cell Huntington’s Disease Models

  2021cites this paper
• Role of Hydrogen Sulfide and Polysulfides in Neurological Diseases: Focus on Protein S-Persulfidation

  2020cites this paper
• Fibroblast growth factor 9 stimulates neurite outgrowth through NF-kB signaling in striatal cell Huntington’s disease models

  2020cites this paper
• FGF9 induces neurite outgrowth upon ERK signaling in knock-in striatal Huntington's disease cells.

  2020cites this paper
• Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities

  2019cites this paper
• Impaired Redox Signaling in Huntington’s Disease: Therapeutic Implications

  2019cites this paper
• 5-HT1A Receptor Agonist Promotes Retinal Ganglion Cell Function by Inhibiting OFF-Type Presynaptic Glutamatergic Activity in a Chronic Glaucoma Model

  2019cites this paper
• Regulation of in vivo excitatory/inhibitory balance by the cystine/glutamate exchanger system xc-

  2018cites this paper
• Cysteine Metabolism in Neuronal Redox Homeostasis.

  2018cites this paper
• Astrocyte truncated tropomyosin receptor kinase B mediates brain‐derived neurotrophic factor anti‐apoptotic effect leading to neuroprotection

  2018cites this paper
• Regulators of the transsulfuration pathway

  2018cites this paper
• Gasotransmitter hydrogen sulfide signaling in neuronal health and disease.

  2017cites this paper
• Synaptopathic mechanisms of neurodegeneration and dementia: Insights from Huntington’s disease

  2017cites this paper
• Comparative analysis of antibodies to xCT (Slc7a11): Forewarned is forearmed

  2016cites this paper
• Transcriptional control of amino acid homeostasis is disrupted in Huntington’s disease

  2016cites this paper
• N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington's disease.

  2016cites this paper
• The importance of the excitatory amino acid transporter 3 (EAAT3).

  2016cites this paper
• Chronic Glutamate Toxicity in Neurodegenerative Diseases—What is the Evidence?

  2015cites this paper
• Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.

  2015cites this paper
• Main path and byways: non‐vesicular glutamate release by system xc− as an important modifier of glutamatergic neurotransmission

  2015cites this paper